Global Dengue Virus Diagnostic Tests Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Dengue Virus Diagnostic Tests Market Research Report 2024
Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
According to MRAResearch’s new survey, global Dengue Virus Diagnostic Tests market is projected to reach US$ 4188 million in 2033, increasing from US$ 3250.3 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dengue Virus Diagnostic Tests market research.
Key companies engaged in the Dengue Virus Diagnostic Tests industry include Alere, Biogate, NovaBios Laboratories Diagnostics, Rapikit, Wondfo, BTNX, GENESIS, Boson Biotech and Adaltis, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Dengue Virus Diagnostic Tests were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Dengue Virus Diagnostic Tests market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Dengue Virus Diagnostic Tests market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Alere
Biogate
NovaBios Laboratories Diagnostics
Rapikit
Wondfo
BTNX
GENESIS
Boson Biotech
Adaltis
AccuBio Tech
Mediven
NTBIO
Segment by Type
Dengue NS1Ag Test
Dengue IgG/IgM Test
Dengue NS1 Ag-IgG/IgM Test
Hospital
Research Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Dengue Virus Diagnostic Tests report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Dengue Virus Diagnostic Tests market is projected to reach US$ 4188 million in 2033, increasing from US$ 3250.3 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dengue Virus Diagnostic Tests market research.
Key companies engaged in the Dengue Virus Diagnostic Tests industry include Alere, Biogate, NovaBios Laboratories Diagnostics, Rapikit, Wondfo, BTNX, GENESIS, Boson Biotech and Adaltis, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Dengue Virus Diagnostic Tests were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Dengue Virus Diagnostic Tests market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Dengue Virus Diagnostic Tests market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Alere
Biogate
NovaBios Laboratories Diagnostics
Rapikit
Wondfo
BTNX
GENESIS
Boson Biotech
Adaltis
AccuBio Tech
Mediven
NTBIO
Segment by Type
Dengue NS1Ag Test
Dengue IgG/IgM Test
Dengue NS1 Ag-IgG/IgM Test
Segment by Application
Hospital
Research Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Dengue Virus Diagnostic Tests report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices